233 related articles for article (PubMed ID: 23527952)
1. A prospective randomized clinical trial of vincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immune-mediated thrombocytopenia in dogs.
Balog K; Huang AA; Sum SO; Moore GE; Thompson C; Scott-Moncrieff JC
J Vet Intern Med; 2013; 27(3):536-41. PubMed ID: 23527952
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs.
Bianco D; Armstrong PJ; Washabau RJ
J Vet Intern Med; 2009; 23(5):1071-8. PubMed ID: 19674280
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs.
Bianco D; Armstrong PJ; Washabau RJ
J Vet Intern Med; 2007; 21(4):694-9. PubMed ID: 17708388
[TBL] [Abstract][Full Text] [Related]
4. Canine idiopathic thrombocytopenic purpura.
Lewis DC; Meyers KM
J Vet Intern Med; 1996; 10(4):207-18. PubMed ID: 8819045
[TBL] [Abstract][Full Text] [Related]
5. Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003).
Putsche JC; Kohn B
J Am Anim Hosp Assoc; 2008; 44(5):250-7. PubMed ID: 18762561
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory and immunosuppressive drug protocols in the treatment of canine primary immune thrombocytopenia, a scoping review.
Kristiansen PS; Nielsen LN
Acta Vet Scand; 2021 Dec; 63(1):54. PubMed ID: 34961516
[TBL] [Abstract][Full Text] [Related]
7. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia.
Whelan MF; O'Toole TE; Chan DL; Rozanski EA; DeLaforcade AM; Crawford SL; Cotter SM
J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):158-64. PubMed ID: 19691566
[TBL] [Abstract][Full Text] [Related]
8. Comparison of platelet count recovery with use of vincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs.
Rozanski EA; Callan MB; Hughes D; Sanders N; Giger U
J Am Vet Med Assoc; 2002 Feb; 220(4):477-81. PubMed ID: 11860242
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
10. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Gedik Y; Orhan F
Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs].
Oggier D; Tomsa K; Mevissen M; Glaus T
Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic options for immune-mediated thrombocytopenia.
Nakamura RK; Tompkins E; Bianco D
J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):59-72. PubMed ID: 22316417
[TBL] [Abstract][Full Text] [Related]
13. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
[TBL] [Abstract][Full Text] [Related]
14. Human intravenous immunoglobulin use for hematological immune-mediated disease in dogs.
Kane BK; Greer RM
J Am Vet Med Assoc; 2023 Jul; 261(7):1004-1010. PubMed ID: 37072115
[TBL] [Abstract][Full Text] [Related]
15. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune-mediated thrombocytopenia.
Stikeman E; Bianco D
J Small Anim Pract; 2024 May; 65(5):338-345. PubMed ID: 38239177
[TBL] [Abstract][Full Text] [Related]
16. Vincristine in the treatment of thrombocytopenia in five dogs.
Greene CE; Scoggin J; Thomas JE; Barsanti JA
J Am Vet Med Assoc; 1982 Jan; 180(2):140-3. PubMed ID: 7061310
[TBL] [Abstract][Full Text] [Related]
17. Application of vincristine-loaded platelet therapy in three dogs with refractory immune-mediated thrombocytopenia.
Park HJ; Kim JW; Song KH; Seo KW
J Vet Sci; 2015; 16(1):127-30. PubMed ID: 25269722
[TBL] [Abstract][Full Text] [Related]
18. Studies of platelet-bound and serum platelet-bindable immunoglobulins in dogs with idiopathic thrombocytopenic purpura.
Lewis DC; Meyers KM
Exp Hematol; 1996 May; 24(6):696-701. PubMed ID: 8635525
[TBL] [Abstract][Full Text] [Related]
19. Neutropenia in dogs receiving vincristine for treatment of presumptive immune-mediated thrombocytopenia.
LaQuaglia KA; Robertson JB; Lunn KF
J Vet Intern Med; 2021 Jan; 35(1):226-233. PubMed ID: 33421218
[TBL] [Abstract][Full Text] [Related]
20. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
